Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions
Chana A. Sacks(Harvard University), Ameet Sarpatwari(Brigham and Women's Hospital), Victor L. Van de Wiele(Brigham and Women's Hospital), Lajja Patel(Brigham and Women's Hospital), Lisa A. Fulchino(Brigham and Women's Hospital), Aaron S. Kesselheim(Brigham and Women's Hospital)
Cited by 51
Related Papers
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure
|Journal of Antimicrobial Chemotherapy|2018|160
Paradigm Shifts in Heart-Failure Therapy — A Timeline
|New England Journal of Medicine|2014|114
Burden of Changes in Pill Appearance for Patients Receiving Generic Cardiovascular Medications After Myocardial Infarction
|Annals of Internal Medicine|2014|84
Generating comparative evidence on new drugs and devices before approval
|The Lancet|2020|80